Pages that link to "Q35582687"

The following pages link to Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study (Q35582687):

Displaying 49 items.

• What explains the increased rate of thromboses among the elderly? Pathophysiological data (Q30999497) (← links)
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation (Q33647003) (← links)
• The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood. (Q33685763) (← links)
• Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know (Q33801932) (← links)
• The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor (Q33901363) (← links)
• Nonvalvular atrial fibrillation: evidence for a prothrombotic state (Q34025550) (← links)
• Atrial fibrillation and stroke: what we know, what's new, and what we should do now (Q34025564) (← links)
• Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management (Q34045019) (← links)
• Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease (Q34045024) (← links)
• Pulmonary embolism in the elderly (Q34196135) (← links)
• An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme (Q34225836) (← links)
• Risk factors for venous and arterial thrombosis (Q34988616) (← links)
• Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment (Q35081853) (← links)
• Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses (Q35582723) (← links)
• Prevention of venous thromboembolism after stroke (Q35610118) (← links)
• Characterization of the hypercoagulable state in patients with sickle cell disease. (Q36328563) (← links)
• Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease (Q36369902) (← links)
• Protein C in critical illness (Q37508524) (← links)
• The hemostatic system through aging and menopause. (Q37610388) (← links)
• Endothelial progenitor cell senescence--is there a role for estrogen? (Q37645668) (← links)
• Interventional stroke therapies in the elderly: are we helping? (Q37960763) (← links)
• Mechanisms of vitamin K antagonism (Q38020339) (← links)
• Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond (Q38129719) (← links)
• The impact of frailty on coagulation and responses to warfarin in acute older hospitalised patients with atrial fibrillation: a pilot study. (Q38931729) (← links)
• Risk factors for thromboembolism: pathophysiology and detection (Q39429597) (← links)
• Activation markers of coagulation (Q40582622) (← links)
• Lipoproteins and the haemostatic system in atherothrombotic disorders (Q40582663) (← links)
• Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients (Q40627711) (← links)
• Endovascular mechanical recanalization of acute ischaemic stroke in octogenarians (Q41359514) (← links)
• Reactivation of the coagulation system: rationale for long-term antithrombotic treatment (Q41593838) (← links)
• Natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke (Q43923082) (← links)
• Procedural predictors of outcome in patients undergoing endovascular therapy for acute ischemic stroke (Q44971535) (← links)
• Antithrombotic agents in the treatment of severe sepsis (Q46576624) (← links)
• Natural anticoagulants, aging, and thromboembolism (Q50534746) (← links)
• Fresh frozen plasma quality: relation to age and gender of blood donors (Q51438836) (← links)
• The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial. (Q52131991) (← links)
• Thrombotic preparedness in aging: a translatable construct for thrombophilias? (Q57113823) (← links)
• Disseminated intravascular coagulation (Q67594376) (← links)
• Pulmonary embolism in the elderly (Q68004018) (← links)
• Procoagulant activity and intimal dysfunction in IDDM (Q72221860) (← links)
• No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation (Q73295920) (← links)
• Impaired Hemorheology in the Aged Associated with Oxidative Stress (Q74308304) (← links)
• Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease (Q74397645) (← links)
• Diurnal rhythms and hemostatic factors in atrial fibrillation (Q77120568) (← links)
• A mathematical model of the background state of the blood coagulation system (Q77185635) (← links)
• Genetic mechanisms of age regulation of protein C and blood coagulation (Q77220852) (← links)
• Rational antithrombotic therapy and prophylaxis in elderly, immobile patients (Q77306749) (← links)
• Relative influence of age and thrombotic history on hemostatic parameters (Q77357100) (← links)
• Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states (Q78018765) (← links)